Gnb5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GNB5
| Symbol | GNB5 |
| Full Name | G Protein Subunit Beta 5 |
| Chromosome | 15q21.2 |
| NCBI Gene ID | 10681 |
| OMIM | 609963 |
| Ensembl ID | ENSG00000068678 |
| UniProt ID | O43472 |
| Encoded Protein | GNB5 Protein |
| Associated Diseases | Neurodevelopmental Disorders, Cardiac Conduction Defects, epilepsy |
The GNB5 gene encodes GNB5 Protein, a G protein beta subunit (RGS family) that plays critical roles in G-protein beta subunit with RGS domain regulating G-protein signaling. This gene is implicated in the pathogenesis of several neurodegenerative diseases through its involvement in GPCR signaling, neuronal development, cardiac function.
GNB5 encodes a unique G protein β subunit that contains a C-terminal RGS (Regulator of G protein Signaling) domain, giving it dual functionality as both a Gβ subunit and a GTPase-activating protein. This makes GNB5 particularly effective at regulating G protein-coupled receptor (GPCR) signaling. GNB5 is essential for normal development, as knockout mice show embryonic lethality with severe developmental defects. In the nervous system, GNB5 regulates synaptic transmission and neuronal excitability through modulation of various GPCR pathways, including muscarinic cholinergic, GABAergic, and dopaminergic signaling.
| Disease | Inheritance | Key Mutations |
|---|---|---|
| Neurodevelopmental Disorders | Various | Pathogenic variants |
| Cardiac Conduction Defects | Various | Pathogenic variants |
| epilepsy | Various | Pathogenic variants |
Biallelic mutations in GNB5 cause a neurodevelopmental disorder characterized by intellectual disability, seizures, movement disorders, and cardiac conduction defects. The disease, known as GNB5-related disorder, presents with variable phenotypes including autism spectrum disorder, hypotonia, and ataxia. GNB5 mutations disrupt both the Gβγ signaling function and the RGS GAP activity, leading to dysregulated GPCR signaling during development.
GNB5 is widely expressed in fetal and adult tissues, with highest expression in the brain, heart, and endocrine organs. In the brain, it is expressed in various regions including the cerebral cortex, hippocampus, cerebellum, and basal ganglia.
The study of Gnb5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.